Equities analysts predict that II-VI Incorporated (NASDAQ:IIVI – Get Rating) will report earnings per share (EPS) of $0.86 for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for II-VI’s earnings. The lowest EPS estimate is $0.83 and the highest is $0.95. II-VI reported earnings per share of $0.91 during the same quarter last year, which indicates a negative year over year growth rate of 5.5%. The company is scheduled to announce its next earnings report on Monday, January 1st.
According to Zacks, analysts expect that II-VI will report full-year earnings of $3.60 per share for the current financial year, with EPS estimates ranging from $3.47 to $3.80. For the next fiscal year, analysts anticipate that the firm will post earnings of $4.35 per share, with EPS estimates ranging from $4.00 to $4.75. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow II-VI.
II-VI (NASDAQ:IIVI – Get Rating) last announced its quarterly earnings results on Wednesday, February 9th. The scientific and technical instruments company reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.05. II-VI had a net margin of 9.57% and a return on equity of 13.66%. The business had revenue of $806.82 million during the quarter, compared to analysts’ expectations of $816.20 million. During the same period last year, the business earned $0.89 earnings per share.
Shares of NASDAQ IIVI traded down $0.66 during midday trading on Wednesday, hitting $64.56. The company’s stock had a trading volume of 25,120 shares, compared to its average volume of 1,307,196. The business’s fifty day simple moving average is $68.45 and its two-hundred day simple moving average is $65.51. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.00 and a quick ratio of 1.61. II-VI has a 1 year low of $54.35 and a 1 year high of $83.45. The firm has a market capitalization of $6.86 billion, a price-to-earnings ratio of 29.45, a price-to-earnings-growth ratio of 1.47 and a beta of 1.45.
In other news, CFO Mary Jane Raymond sold 1,000 shares of II-VI stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $72.00, for a total value of $72,000.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CTO Christopher Koeppen sold 500 shares of II-VI stock in a transaction on Tuesday, January 18th. The shares were sold at an average price of $69.81, for a total transaction of $34,905.00. The disclosure for this sale can be found here. Insiders have sold a total of 15,829 shares of company stock valued at $1,138,407 in the last 90 days. Insiders own 2.50% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. First Horizon Advisors Inc. increased its stake in II-VI by 276.0% in the 4th quarter. First Horizon Advisors Inc. now owns 485 shares of the scientific and technical instruments company’s stock valued at $33,000 after buying an additional 356 shares during the period. IFP Advisors Inc increased its stake in II-VI by 17.4% in the 4th quarter. IFP Advisors Inc now owns 2,934 shares of the scientific and technical instruments company’s stock valued at $201,000 after buying an additional 434 shares during the period. Amalgamated Bank increased its stake in II-VI by 1.6% in the 4th quarter. Amalgamated Bank now owns 75,213 shares of the scientific and technical instruments company’s stock valued at $5,139,000 after buying an additional 1,178 shares during the period. Verity Asset Management Inc. increased its stake in II-VI by 11.7% in the 3rd quarter. Verity Asset Management Inc. now owns 15,444 shares of the scientific and technical instruments company’s stock valued at $917,000 after buying an additional 1,615 shares during the period. Finally, Lindbrook Capital LLC acquired a new position in II-VI in the 4th quarter valued at $140,000. 99.48% of the stock is currently owned by institutional investors.
II-VI Company Profile (Get Rating)
II-VI, Inc engages in the development, refinement, manufacturing, and marketing of engineered materials and opto-electronic components and devices for precision in the field of industrial materials processing, optical communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences, and automotive applications and markets.
- Get a free copy of the StockNews.com research report on II-VI (IIVI)
- 3 Undervalued Stocks The Insiders Are Buying
- The Market For Gamestop Is Near A Turning Point
- PayPal Stock is Still Ready for Bargain Hunting
- It’s Personal: 3 Personal Care Stocks to Own in Volatile Markets
- Conagra Stock Has More Room to Grow
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for II-VI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI and related companies with MarketBeat.com's FREE daily email newsletter.